Cover Image
市場調查報告書

歐洲的醫藥品、醫療產業 (季度更新報告)

Europe Pharmaceuticals and Healthcare Report Q2 2017

出版商 BMI Research 商品編碼 363589
出版日期 內容資訊 英文 47 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的醫藥品、醫療產業 (季度更新報告) Europe Pharmaceuticals and Healthcare Report Q2 2017
出版日期: 2017年04月26日 內容資訊: 英文 47 Pages
簡介

本報告提供歐洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區的詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 歐洲市場最新形勢

SWOT分析

  • 歐洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 歐洲:風險/利潤指標

市場概況

  • 歐洲市場最新形勢

產業的趨勢與發展

  • 歐洲市場最新形勢

域內市場概況

  • 歐洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1024

BMI View:While the ageing of populations will increase the prevalence of chronic diseases across Europe, driving up demand for medicines, the outlook for the emerging and developed Europe sub-regions is divergent. In emerging European markets, the heavy focus on expansion of healthcare access will drive its outperformance. Cost containment will be prominent throughout the region although this will manifest in different forms; Western European markets will be hit by stricter reimbursement levels and pricing control while generic substitution policies will become more prominent in emerging Europe.

Headline Expenditure Projections

  • Pharmaceuticals: USD311.8bn in 2016 to USD309.8bn in 2017; -0.7% in US dollar terms. Forecast revised upwards from last quarter.
  • Healthcare: USD1,823bn in 2016 to USD1,825bn in 2016; 0.1% in US dollar terms. Forecast revised upwards from last quarter.

BMI Economic View

Despite the political risks to the eurozone (see below), economic growth momentum is improving, aided by a more supportive global growth backdrop. Our growth forecast for the bloc has been revised up this year to 1.6%. That said, structural factors including large debt loads and underlying eurozone imbalances continue to weigh on growth potential. Economic growth in Central and Eastern Europe will rebound from the drop in EU structural funding in 2016, averaging 3.0% in 2017.

Table of Contents

BMI Industry View

  • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (2015-2021)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: REGIONAL PHARMACEUTICAL SALES, HISTORICAL DATA AND FORECASTS (2013-2021)
  • Healthcare Market Forecast
    • Table: REGIONAL HEALTHCARE EXPENDITURE TRENDS, HISTORICAL DATA AND FORECASTS (2013-2021)

Industry Risk Reward Index

  • Western Europe Risk/Reward Index
  • Central And Eastern Europe Risk/Reward Index

Market Overview

Industry Trend Analysis

  • Regional Themes - Europe

Industry Trends & Developments

  • Regional Round-Up
    • Table: Europe Pharmaceutical Market (USDbn)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top